Participant flow18

How many started, completed or left each group, period by period.

1 to 18 of 18

Period	Milestone	Group	Participants
Overall Study	STARTED	20 mg Tamoxifen	241
Overall Study	STARTED	10 mg Tamoxifen	243
Overall Study	STARTED	5 mg Tamoxifen	240
Overall Study	STARTED	2.5 mg Tamoxifen	235
Overall Study	STARTED	1 mg Tamoxifen	239
Overall Study	STARTED	0 mg Tamoxifen	242
Overall Study	COMPLETED	20 mg Tamoxifen	171
Overall Study	COMPLETED	10 mg Tamoxifen	167
Overall Study	COMPLETED	5 mg Tamoxifen	157
Overall Study	COMPLETED	2.5 mg Tamoxifen	159
Overall Study	COMPLETED	1 mg Tamoxifen	174
Overall Study	COMPLETED	0 mg Tamoxifen	183
Overall Study	NOT COMPLETED	20 mg Tamoxifen	70
Overall Study	NOT COMPLETED	10 mg Tamoxifen	76
Overall Study	NOT COMPLETED	5 mg Tamoxifen	83
Overall Study	NOT COMPLETED	2.5 mg Tamoxifen	76
Overall Study	NOT COMPLETED	1 mg Tamoxifen	65
Overall Study	NOT COMPLETED	0 mg Tamoxifen	59

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03346200/flow